Paper16638822
Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice.
Carvalho-Filho MA and 4 others. Am J Physiol Endocrinol Metab, 2006. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice. Papers, record 16638822. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16638822
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Insulin Resistance | Major topic |
| Lipopolysaccharides | Major topic |
| Nitric Oxide Synthase Type II | Major topic |
| Phosphoproteins | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Receptor, Insulin | Major topic |
| Adipose Tissue | |
| Animals | |
| Blood Glucose | |
| Insulin | |
| Insulin Receptor Substrate Proteins | |
| Liver | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Knockout | |
| Muscle, Skeletal | |
| Nitrosation | |
| Phosphorylation | |
| Protein Processing, Post-Translational |
Source PubMed
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42900998 | Endothelial nitric oxide signaling in cellular and systemic metabolism. | Redox Biol | 2026 | https://conductscience.org/library/papers/42900998 | PubMed |
| 41373704 | Emerging Roles of Post-Translational Modifications in Metabolic Homeostasis and Type 2 Diabetes. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373704 | PubMed |
| 40413611 | Microbial metabolism mediates the deteriorative effects of sedentary behaviour on insulin resistance. | Clin Transl Med | 2025 | https://conductscience.org/library/papers/40413611 | PubMed |
| 38056462 | An enzyme that selectively S-nitrosylates proteins to regulate insulin signaling. | Cell | 2023 | https://conductscience.org/library/papers/38056462 | PubMed |
| 37262088 | Redox regulation in diabetic kidney disease. | Am J Physiol Renal Physiol | 2023 | https://conductscience.org/library/papers/37262088 | PubMed |
| 35127558 | Vancomycin-Induced Modulation of Gram-Positive Gut Bacteria and Metabolites Remediates Insulin Resistance in iNOS Knockout Mice. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/35127558 | PubMed |
| 34789923 | The manifold roles of protein S-nitrosylation in the life of insulin. | Nat Rev Endocrinol | 2022 | https://conductscience.org/library/papers/34789923 | PubMed |
| 32848770 | Bradykinin B2 Receptor Signaling Increases Glucose Uptake and Oxidation: Evidence and Open Questions. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32848770 | PubMed |
| 31192483 | Inducible nitric oxide synthase: Regulation, structure, and inhibition. | Med Res Rev | 2020 | https://conductscience.org/library/papers/31192483 | PubMed |
| 30233499 | Insulin Resistance in HIV-Patients: Causes and Consequences. | Front Endocrinol (Lausanne) | 2018 | https://conductscience.org/library/papers/30233499 | PubMed |
| 29258520 | Metabolic Reponses to a physical exercise session in women with excess body mass: randomized clinical trial. | Lipids Health Dis | 2017 | https://conductscience.org/library/papers/29258520 | PubMed |
| 29229986 | High-fat diet-induced obesity impairs insulin signaling in lungs of allergen-challenged mice: Improvement by resveratrol. | Sci Rep | 2017 | https://conductscience.org/library/papers/29229986 | PubMed |
| 28704952 | The Inhibitory Effect of Tartary Buckwheat Extracts on Adipogenesis and Inflammatory Response. | Molecules | 2017 | https://conductscience.org/library/papers/28704952 | PubMed |
| 28180062 | Blocking iNOS and endoplasmic reticulum stress synergistically improves insulin resistance in mice. | Mol Metab | 2017 | https://conductscience.org/library/papers/28180062 | PubMed |
| 26246742 | Luteolin is a bioflavonoid that attenuates adipocyte-derived inflammatory responses via suppression of nuclear factor-κB/mitogen-activated protein kinases pathway. | Pharmacogn Mag | 2015 | https://conductscience.org/library/papers/26246742 | PubMed |
| 24878261 | Regulation of obesity and insulin resistance by nitric oxide. | Free Radic Biol Med | 2014 | https://conductscience.org/library/papers/24878261 | PubMed |
| 23840101 | Influence of gut microbiota on subclinical inflammation and insulin resistance. | Mediators Inflamm | 2013 | https://conductscience.org/library/papers/23840101 | PubMed |
| 23314241 | Nitric oxide activates intradomain disulfide bond formation in the kinase loop of Akt1/PKBα after burn injury. | Int J Mol Med | 2013 | https://conductscience.org/library/papers/23314241 | PubMed |
| 22995863 | iNOS inhibitor, L-NIL, reverses burn-induced glycogen synthase kinase-3β activation in skeletal muscle of rats. | Metabolism | 2013 | https://conductscience.org/library/papers/22995863 | PubMed |
| 22991447 | Targeted disruption of inducible nitric oxide synthase protects against aging, S-nitrosation, and insulin resistance in muscle of male mice. | Diabetes | 2013 | https://conductscience.org/library/papers/22991447 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16638822
GET https://conductscience.org/api/papers/v1/16638822/cited_by?page=2